Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 sept. 2025 08h05 HE | Source: Quotient Therapeutics, Inc.

Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer

CAMBRIDGE, Mass., and CAMBRIDGE, United Kingdom, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced...
07 nov. 2024 07h30 HE | Source: Quotient Therapeutics, Inc.

Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors

CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics, today announced the appointment of Sir Mene Pangalos, Ph.D., to the company’s Board...
07 août 2024 07h30 HE | Source: Quotient Therapeutics, Inc.

Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics, today announced the appointment of the company’s academic co-founder from the...